Seoul Pharma Co. Ltd (018680) — Capital Reinvestment Ratio
Seoul Pharma Co. Ltd (018680) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.07 Billion) in capital expenditures (₩89.75 Million). Check Seoul Pharma Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Seoul Pharma Co. Ltd Capital Reinvestment Ratio (2009–2023)
This chart tracks Seoul Pharma Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Seoul Pharma Co. Ltd.
Annual Capital Reinvestment Ratio for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year Capital Reinvestment Ratio for Seoul Pharma Co. Ltd from 2009 to 2023. See 018680 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.36x | ₩5.26 Billion | ₩1.89 Billion | ▲ +207.5% |
| 2020 | 0.12x | ₩5.74 Billion | ₩671.25 Million | ▲ +119.1% |
| 2019 | 0.05x | ₩2.93 Billion | ₩156.43 Million | ▼ -94.6% |
| 2015 | 0.98x | ₩1.42 Billion | ₩1.40 Billion | ▼ -44.5% |
| 2014 | 1.77x | ₩1.48 Billion | ₩2.62 Billion | ▼ -9.0% |
| 2012 | 1.95x | ₩9.22 Billion | ₩17.95 Billion | ▲ +74.2% |
| 2011 | 1.12x | ₩4.86 Billion | ₩5.43 Billion | ▼ -77.4% |
| 2009 | 4.95x | ₩1.23 Billion | ₩6.11 Billion | — |